Skip to main content

EDITORIAL article

Front. Oncol.
Sec. Gastrointestinal Cancers: Colorectal Cancer
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1474157
This article is part of the Research Topic Hereditary Colorectal Cancer Syndromes and Risk Assessment in the Era of Precision Medicine View all 7 articles

Precision Medicine: Innovations in Diagnosing and Treating Hereditary Colorectal Cancer Syndromes

Provisionally accepted
Gregory Idos Gregory Idos 1*Gad Rennert Gad Rennert 2Kevin McDonnell Kevin McDonnell 1
  • 1 City of Hope National Medical Center, Duarte, United States
  • 2 Technion Israel Institute of Technology, Haifa, Haifa, Israel

The final, formatted version of the article will be published soon.

    Keywords: precision medicine, hereditary, colorectal cancer, Genetic Testing, Chemoprevention

    Received: 01 Aug 2024; Accepted: 17 Sep 2024.

    Copyright: © 2024 Idos, Rennert and McDonnell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Gregory Idos, City of Hope National Medical Center, Duarte, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.